 BEDFORD, Mass.--BUSINESS WIRE--Stoke Therapeutics, Inc., Nasdaq: STOK, a clinical-stage biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that Chief Executive Officer Edward M. Kaye, M.D., will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 4:30 p.m. ET. A live audio webcast of the presentation will be available on the Investors Media s 